Background/Aims: Conversion rates to dementia are known to be high for patients with mild cognitive impairment (MCI), but the diagnosis of MCI is very time-consuming. Since the Clock Drawing Test (CDT) is quick to administer, it will be of interest to compare the predictive validity of the CDT and of an MCI diagnosis for the diagnosis of dementia. Methods: In a sample of 384 individuals, CDT scores and the presence of MCI were assessed at baseline and then compared between individuals with an incident dementia diagnosis at follow-up and those without. Multivariate analyses, receiver operating characteristic analyses and values of sensitivity and specificity of the CDT were performed. Results: Individuals with incident dementia had significantly higher CDT scores at baseline than those without dementia. CDT was a significant predictor of incident dementia after adjusting for other factors. CDT reached a sensitivity of 68% and specificity of 65%. The area under the receiver operating characteristic curve of CDT was 0.70 and therefore slightly lower than for MCI diagnosis (0.78). Conclusions: Because of the only slightly lower predictive value of the CDT, its quick application and scoring compared to the MCI concept applied, it will be worthwhile to improve the CDT scoring system in order to increase the predictive validity in dementia.

Keywords:
Clock Drawing Test, Dementia, Predictive validity, Mild cognitive impairment
1.
Fratiglioni L, De Ronchi D, Aguero-Torres H: Worldwide prevalence and incidence of dementia. Drugs Aging 1999;15:365–375.
2.
Weimer DL, Sager MA: Early identification and treatment of Alzheimer’s disease: social and fiscal outcomes. Alzheimers Dement 2009;5:215–226.
3.
Middleton LE, Yaffe K: Promising strategies for the prevention of dementia. Arch Neurol 2009;66:1210–1215.
4.
Qiu C, Kivipelto M, von Strauss E: Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 2009;11:111–128.
5.
Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–1992.
6.
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC: Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–246.
7.
Busse A, Hensel A, Guhne U, Angermeyer MC, Riedel-Heller SG: Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 2006;67:2176–2185.
8.
Zanetti M, Ballabio C, Abbate C, Cutaia C, Vergani C, Bergamaschini L: Mild cognitive impairment subtypes and vascular dementia in community-dwelling elderly people: a 3-year follow-up study. J Am Geriatr Soc 2006;54:580–586.
9.
Panza F, D’Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, Pilotto A, Argentieri G, Scapicchio PL, Scafato E, Capurso A, Solfrizzi V: Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry 2005;13:633–644.
10.
Defranceso M, Schocke M, Messner HJ, Deisenhammer EA, Hinterhuber H, Marksteiner J, Weiss EM: Conversion from MCI (mild cognitive impairment) to Alzheimer’s disease: diagnostic options and predictors (in German). Neuropsychiatr 2010;24:88–98.
11.
Werner P, Korczyn AD: Mild cognitive impairment: conceptual, assessment, ethical, and social issues. Clin Interv Aging 2008;3:413–420.
12.
Shulman KI: Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 2000;15:548–561.
13.
Paganini-Hill A, Clark LJ, Henderson VW, Birge SJ: Clock drawing: analysis in a retirement community. J Am Geriatr Soc 2001;49:941–947.
14.
Ehreke L, Luppa M, König HH, Riedel-Heller SG: Is the Clock Drawing Test a screening tool for the diagnosis of mild cognitive impairment? A systematic review. Int Psychogeriatr 2010;22:56–63.
15.
Chiu YC, Li CL, Lin KN, Chiu YF, Liu HC: Sensitivity and specificity of the Clock Drawing Test, incorporating Rouleau scoring system, as a screening instrument for questionable and mild dementia: scale development. Int J Nurs Stud 2008;45:75–84.
16.
Esteban-Santillan C, Praditsuwan R, Ueda H, Geldmacher DS: Clock drawing test in very mild Alzheimer’s disease. J Am Geriatr Soc 1998;46:1266–1269.
17.
Powlishta KK, Von Dras DD, Stanford A, Carr DB, Tsering C, Miller JP, Morris JC: The clock drawing test is a poor screen for very mild dementia. Neurology 2002;59:898–903.
18.
Seigerschmidt E, Mosch E, Siemen M, Förstl H, Bickel H: The clock drawing test and questionable dementia: reliability and validity. Int J Geriatr Psychiatry 2002;17:1048–1054.
19.
Ferrucci L, Cecchi F, Guralnik JM, Giampaoli S, Lo NC, Salani B, Bandinelli S, Baroni A: Does the Clock Drawing Test predict cognitive decline in older persons independent of the Mini-Mental State Examination? The FINE Study Group. Finland, Italy, The Netherlands Elderly. J Am Geriatr Soc 1996;44:1326–1331.
20.
O’Rourke N, Tuokko H, Hayden S, Lynn BB: Early identification of dementia: predictive validity of the clock test. Arch Clin Neuropsychol 1997;12:257–267.
21.
Babins L, Slater ME, Whitehead V, Chertkow H: Can an 18-point clock-drawing scoring system predict dementia in elderly individuals with mild cognitive impairment? J Clin Exp Neuropsychol 2008;30:173–186.
22.
Riedel-Heller SG, Schork A, Matschinger H, Angermeyer MC: Recruitment procedures and their impact on the prevalence of dementia. Results from the Leipzig Longitudinal Study of the Aged (LEILA75+). Neuroepidemiology 2000;19:130–140.
23.
Riedel-Heller SG, Busse A, Aurich C, Matschinger H, Angermeyer MC: Prevalence of dementia according to DSM-III-R and ICD-10: results of the Leipzig Longitudinal Study of the Aged (LEILA75+) Part 1. Br J Psychiatry 2001;179:250–254.
24.
Zaudig M, Mittelhammer J, Hiller W, Pauls A, Thora C, Morinigo A, Mombour W: SIDAM – a structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R. Psychol Med 1991;21:225–236.
25.
Zaudig M, Hiller W: SIDAM-Handbuch. Strukturiertes Interview für die Diagnose einer Demenz vom Alzheimer Typ, der Multiinfarkt- (oder vaskulären) Demenz und Demenzen anderer Ätiologie nach DSM-III-R, DSM-IV und ICD-10. Bern, Huber, 1996.
26.
Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
27.
Shulman KI, Gold DP, Cohen CA, Zucchero CA: Clock-drawing and dementia in the community: a longitudinal study. Int J Geriatr Psychiatry 1993;8:487–496.
28.
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566–572.
29.
Luck T, Zaudig M, Wiese B, Riedel-Heller SG: SIDAM: Alters- und bildungsspezifische Normen des kognitiven Leistungsteiles nach der neuen CASMIN-Bildungsklassifikation. Z Gerontopsychol Psychiatr 2007;20:31–38.
30.
Brauns H, Steinmann S: Educational reform in France, West-Germany and the United Kingdom. Zuma-Nachrichten 1999;44:7–44.
31.
Youden WJ: Index for rating diagnostic tests. Cancer 1950;3:32–35.
32.
Tuokko H, Hadjistavropoulos T, Miller JA, Beattie BL: The Clock Test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease. J Am Geriatr Soc 1992;40:579–584.
33.
Wolf-Klein GP, Silverstone FA, Levy AP, Brod MS: Screening for Alzheimer’s disease by clock drawing. J Am Geriatr Soc 1989;37:730–734.
34.
Brodaty H, Moore CM: The Clock Drawing Test for dementia of the Alzheimer’s type: a comparison of three scoring methods in a memory disorders clinic. Int J Geriatr Psychiatry 1997;12:619–627.
35.
Blake H, McKinney M, Treece K, Lee E, Lincoln NB: An evaluation of screening measures for cognitive impairment after stroke. Age Ageing 2002;31:451–456.
36.
Förstl H, Bickel H, Frölich L, Gertz HJ, Gutzmann H, Hörr R, Pantel J, Schmidt R, Schönknecht P, Ulm K, Werheid K: MCI-plus: mild cognitive impairment with rapid progression. Part I: prevention and therapy (in German). Dtsch Med Wochenschr 2009;134:39–44.
37.
Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH: Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer’s disease. Biol Psychiatry 2008;64:871–879.
38.
Bäckman L, Small BJ: Cognitive deficits in preclinical Alzheimer’s disease and vascular dementia: patterns of findings from the Kungsholmen Project. Physiol Behav 2007;92:80–86.
39.
Jungwirth S, Zehetmayer S, Bauer P, Weissgram S, Tragl KH, Fischer P: Prediction of Alzheimer dementia with short neuropsychological instruments. J Neural Transm 2009;116:1513–1521.
40.
Madureira S, Verdelho A, Moleiro C, Ferro JM, Erkinjuntti T, Jokinen H, Pantoni L, Fazekas F, Van der FW, Visser M, Waldemar G, Wallin A, Hennerici M, Inzitari D: Neuropsychological predictors of dementia in a three-year follow-up period: data from the LADIS study. Dement Geriatr Cogn Disord 2010;29:325–334.
41.
Leyhe T, Milian M, Muller S, Eschweiler GW, Saur R: The minute hand phenomenon in the Clock Test of patients with early Alzheimer disease. J Geriatr Psychiatry Neurol 2009;22:119–129.
42.
Chen JH, Lin KP, Chen YC: Risk factors for dementia. J Formos Med Assoc 2009;108:754–764.
43.
Azad NA, Al Bugami M, Loy-English I: Gender differences in dementia risk factors. Gend Med 2007;4:120–129.
44.
Korczyn AD: Is dementia preventable? Dialogues Clin Neurosci 2009;11:213–216.
45.
Ngandu T, von Strauss E, Helkala EL, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M: Education and dementia: what lies behind the association? Neurology 2007;69:1442–1450.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.